Tower Research Capital (TRC)’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,684
| Closed | -$3.94K | – | 5983 |
|
|
2024
Q4 | $3.94K | Buy |
6,684
+1,289
| +24% | +$894 | ﹤0.01% | 4559 |
|
|
2024
Q3 | $4.26K | Buy |
5,395
+396
| +8% | +$396 | ﹤0.01% | 4622 |
|
|
2024
Q2 | $6.35K | Sell |
4,999
-1,583
| -24% | -$2.09K | ﹤0.01% | 4589 |
|
|
2024
Q1 | $9.15K | Buy |
6,582
+711
| +12% | +$1.18K | ﹤0.01% | 3887 |
|
|
2023
Q4 | $9.34K | Sell |
5,871
-896
| -13% | -$1.14K | ﹤0.01% | 4404 |
|
|
2023
Q3 | $9.61K | Sell |
6,767
-370
| -5% | -$569 | ﹤0.01% | 4201 |
|
|
2023
Q2 | $11.3K | Sell |
7,137
-4,816
| -40% | -$6.15K | ﹤0.01% | 3987 |
|
|
2023
Q1 | $10K | Buy |
11,953
+7,168
| +150% | +$10.2K | ﹤0.01% | 4421 |
|
|
2022
Q4 | $7K | Buy |
4,785
+205
| +4% | +$339 | ﹤0.01% | 4640 |
|
|
2022
Q3 | $9K | Buy |
4,580
+2,310
| +102% | +$4.84K | ﹤0.01% | 4712 |
|
|
2022
Q2 | $4K | Buy |
2,270
+762
| +51% | +$1.85K | ﹤0.01% | 5275 |
|
|
2022
Q1 | $5K | Buy |
1,508
+836
| +124% | +$2.92K | ﹤0.01% | 5129 |
|
|
2021
Q4 | $3K | Sell |
672
-482
| -42% | -$2.73K | ﹤0.01% | 5516 |
|
|
2021
Q3 | $8K | Buy |
1,154
+589
| +104% | +$4.61K | ﹤0.01% | 4578 |
|
|
2021
Q2 | $6K | Buy |
565
+371
| +191% | +$3.11K | ﹤0.01% | 4650 |
|
|
2021
Q1 | $2K | Buy |
+194
| New | +$1.62K | ﹤0.01% | 5064 |
|